Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sequential determination of ED50 of propofol with remimazolam in obese patients undergoing painless gastrointestinal endoscopy
ChiCTR2100053697Phase 4Recruiting
- Sponsor
- Central Hospital Affiliated to Shandong First Medical University
- Start
- Nov 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of propofol and remimazolam in obesity, sponsored by Central Hospital Affiliated to Shandong First Medical University. Primary endpoints: Blood pressure and Heart rate. Started Nov 2021; status: recruiting.
02
Drugs
propofolremimazolam
03
Conditions
obesity
Beyond the preview
Go deeper on ChiCTR2100053697.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100053697.